B
Bio-Medical Research
Home Page | Slendertone Official
About Bio-Medical Research
In the world of fitness technology, few brands have the longevity of Slendertone. The story begins not with an app, but with a physical device rooted in medical science. Bio-Medical Research (BMR), a Galway-based Irish company, was formally established in 1989, building on over 50 years of expertise in Electrical Muscle Stimulation (EMS) technology. This technology, initially used for medical rehabilitation, was ingeniously packaged into consumer-friendly belts and wearables. The core business was straightforward: apply the proven science of EMS to create products that could tone and strengthen muscles for the general public. BMR successfully marketed the Slendertone brand globally, selling over 10 million devices and becoming a leader in its category. For decades, the company operated as a stable, private entity, manufacturing its products in Ireland and distributing them in over 20 countries. The major turning point was not a blockbuster IPO, but a fight for survival. Starting in 2019, BMR faced a perfect storm of challenges, including a sharp decline in sales in Japan, the economic impact of Brexit, and a global semiconductor shortage that crippled its manufacturing capabilities. Despite efforts to restructure, the company's financial health deteriorated, leading it to seek court protection in March 2022. After a failed attempt to secure a new investor, Bio-Medical Research was wound up and entered liquidation in June 2022. However, the story didn't end there. In a classic case of a brand being more resilient than its corporate owner, Slendertone was acquired in 2023. A new Irish startup, Bio-Medical Science and Technology Ltd., became the new custodians of the brand, relaunching it with a mission to continue its 50-year legacy. This acquisition marked a new chapter, saving a household name from disappearing and allowing the technology to find a new path forward under fresh ownership.
Source: Dealroom company dataNews
Open roles
Bio-Medical Research in the Galway ecosystem
The Bio-Medical Research office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Beechbrook Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bio-Medical Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bio-Medical Research on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


